NUC-7738 Enhances Nivolumab–Relatlimab Response in a PBMC–Melanoma Co-culture Model (ESMO-IO 2026) - Oct 25, 2026 - Abstract #273P; Pres time: Dec 14, 2026; 05:30 PM - 06:30 PM; Location: Churchill Room; No abstract available
Melanoma • Oncology • Solid Tumor
|
|
Anna E. Ca rberry; Hazem Abdullah; Jessie Y. Woon; Paul Reynolds; Peter Mullen; Ying Zhang; David Harrison
|